Building Cognitive Computing for Healthcare
|
|
- Conrad Freeman
- 6 years ago
- Views:
Transcription
1 Building Cognitive Computing for Healthcare Boston University Digital Health Initiative Round Table February 27 th 2017 Patrick McNeillie M.D. Clinical Lead and Senior Architect on Watson for Genomics
2 Agenda Building Cognitive Computing -Defining the Importance of Natural Language Processing (NLP) Applying Cognitive to a Complex Problem Surfacing Valuable Insights in Big Data
3 Moving Beyond Jeopardy: Bringing Cognitive Computing to Healthcare
4 Applying Cognitive Computing to Complex Problems Define Attributes Attribute Extraction Compare to Prior Knowledge Clinical Expert What is the best treatment for a given patient? Stage Stage IIIA IIIA Squamous Cell Squamous Cell Lung Cancer Lung Cancer PD-L1 Receptor PD-L1 Receptor Data Set
5 Applying Cognitive Computing to Complex Problems Define Attributes Attribute Extraction Compare to Prior Knowledge Clinical Expert What is the best treatment for a given patient? Stage Stage IIIA IIIA Squamous Cell Squamous Cell Lung Cancer Lung Cancer PD-L1 Receptor PD-L1 Receptor Stage IIIA PD-L1 Receptor Natural Language Processing Lung Cancer Squamous Cell Data Set
6 Applying Cognitive Computing to Complex Problems Define Attributes Attribute Extraction Compare to Prior Knowledge Clinical Expert What is the best treatment for a given patient? Stage Stage IIIA IIIA Squamous Cell Squamous Cell Lung Cancer Lung Cancer PD-L1 Receptor PD-L1 Receptor Stage IIIA PD-L1 Receptor Natural Language Processing Lung Cancer Squamous Cell Stage IIIA PD-L1 Receptor Atezolizumab Lung Cancer Treatment Squamous Cell Docetaxel Survival: 13.8 Months Survival: 9.6 Months Data Set
7 Applying Cognitive Computing to Complex Problems Define Attributes Attribute Extraction Compare to Prior Knowledge Clinical Expert What is the best treatment for a given patient? Stage Stage IIIA IIIA Squamous Cell Squamous Cell Lung Cancer Lung Cancer PD-L1 Receptor PD-L1 Receptor Stage IIIA PD-L1 Receptor Natural Language Processing Lung Cancer Squamous Cell Stage Stage Squamous Squamous IIIA IIIA Cell Cell Lung Lung Cancer Cancer PD-L1 PD-L1 Receptor Receptor Treatment?? Atezolizumab Docetaxel Survival: 13.8 Months Survival: 9.6 Months Data Set
8 Differences in attribute extraction between Machine Learning and Rules-Based NLP Machine Learning NLP Rules-Based NLP Rule: connect disease to therapy if within 10 words of each other nephrotic syndrome glomerulosclerosis >10 word <10 word <none> cortisol Disease Therapy steroid resistant nephrotic syndrome <subtype> glomerulosclerosis rxdx-101 Disease Therapy <conflict> nephrotic syndrome <conflict> glomerulosclerosis <incorrect> cortisol
9 Applying Cognitive to Genomics
10 Impact on Medical Genomics [COSMIC. Wellcome Trust Sanger Institute. October 2015 ] [Modern Pathology Mar;25(3): (accessed 10/5/2015)]
11 What s the best treatment given a tumor sequence?
12 Ingest & Learn Reference Genomes Molecular Protein Pathways Genomic Databases Clinical Partners (currently 16 centers) Unstructured Text Best Practices Guidelines Patient Data Literature Articles Clinical Trials Conference Reports Process Patient Data Output Report Personalized Driver Alterations and Targeted Therapies
13 Our Approach to NLP Boston University Digital Health Initiative Round Table Focused Annotation Specialist Team (FAST) NLP Expert Annotator Label Documents Standardize Ontologies and Dictionaries Train Machine Learning Measure Performance 1.00 Enable Integration & Reuse Reduce Bias
14 Annotating mentions Boston University Digital Health Initiative Round Table 2014 International Business Machines Corporation 14
15 Annotating relationships Boston University Digital Health Initiative Round Table 2014 International Business Machines Corporation 15
16 Ensuring Agreement: Measuring Kappa Scores 100% Agreement Domain Experts Annotators Time
17 Concepts Detection: Compare to a standard and iterate Boston University Digital Health Initiative Round Table Model Performance for Labeling Concepts When a plateau is reached, development teams need to assess if the plateau is secondary to bias or variance to efficiently apply resources and iterate F1 Precision Recall
18 Relationship Detection: Compare to a standard and iterate Model Performance for Labeling Relationships When a plateau is reached, development teams need to assess if the plateau is secondary to bias or variance to efficiently apply resources and iterate F1 Precision Recall
19 Maintaining Context Within and Across Documents <text>unexpectedly, we find that EGFR A763_Y764insFQEA is highly sensitive to EGFR TKIs in vitro, and patients whose NSCLCs harbor this mutation respond to erlotinib.</text> ="alters"> <relation rid="s6-r1" subtype="other" type="alters"> <rel_entity_arg argnum="1" eid="e-39"/> <rel_entity_arg argnum="2" eid="c1"/> <relmentions> <relmention class="specific" modality="asserted" rmid="s6-r1-1" score="1" tense="unspecified"> <rel_mention_arg argnum="1" mid="s6-m6">a763_y764insfqea</rel_mention_arg> <rel_mention_arg argnum="2" mid="s6-m0">egfr</rel_mention_arg> <relation rid="s6-r5" subtype="other" type="drives"> <rel_entity_arg argnum="1" eid="c1"/> <rel_entity_arg argnum="2" eid="c3"/> <relmentions> <relmention class="specific" modality="asserted" rmid="s6-r5-1" score="1" tense="unspecified"> <rel_mention_arg argnum="1" mid="s6-m0">egfr</rel_mention_arg> Variant s6-m6 A763_Y764insFQEA type=category Rel: Alters PMID: Gene/Protein S6-m0 EGFR type=concept <rel_mention_arg argnum="2" mid="s6-m8">egfr TKIs</rel_mention_arg> Gene/Protein S6-m0 EGFR type=concept Rel: Sensitive PMID: Cancer Type S6-m8 EGFR TKIs type=concept
20 Clinical Knowledge: Example Graph
21 Boston University Digital Health Initiative Round Table Clinical Knowledge: Extracted Data from Corpus of Documents
22 Boston University Digital Health Initiative Round Table Clinical Knowledge: Extracted Data from Corpus of Documents
23 Output Sample from Knowledge Graph Query
24 Leveraging Literature Articles to Support Clinical Care
25 Leveraging Literature Articles to Support Clinical Care
26 Summary
27 Empowering Healthcare Professionals with Cognitive Computing The Process of Building Work Closely with domain experts Leverage tools (like NLP) to extract unstructured concepts and their associations Combine unstructured and structured data to create knowledge Value of Applying to Healthcare Increased efficiency Reduced bias Scaling expert knowledge Innovating across a complex domain Validate and iterate with domain experts With Cognitive computing, the extraction of information from clinical data and published literature can empower healthcare professionals to stay up-to-date, focus on the complex problems, and spend more time with caring for patients.
28 Questions? (remember, I m not Watson..)
How can Natural Language Processing help MedDRA coding? April Andrew Winter Ph.D., Senior Life Science Specialist, Linguamatics
How can Natural Language Processing help MedDRA coding? April 16 2018 Andrew Winter Ph.D., Senior Life Science Specialist, Linguamatics Summary About NLP and NLP in life sciences Uses of NLP with MedDRA
More informationHow Big Data and Advanced Analytics Can Improve Population Health: Now and In the Near Future
How Big Data and Advanced Analytics Can Improve Population Health: Now and In the Near Future William J. Kassler, MD, MPH Deputy Chief Health Officer Lead Population Health Officer Precision Medicine Completion
More informationThe Human Behaviour-Change Project
The Human Behaviour-Change Project Participating organisations A Collaborative Award funded by the www.humanbehaviourchange.org @HBCProject This evening Opening remarks from the chair Mary de Silva, The
More informationIntroduction to the Partners Biobank Portal. December 2016
Introduction to the Partners Biobank Portal December 2016 Agenda About the Partners Biobank About the Biobank Portal Data Types in the Biobank Sample types DNA. Plasma and Serum Consent Genomic Data Health
More informationWatson Summit Prague 2017
Watson for Oncology Matěj Adam Watson Health Executive May 2017 Watson Summit Prague 2017 an IBM Company Leadership & 23 Years Patent Leadership Research Spend Global Presence Technology 7300+ 2015 $6B
More informationUsing Natural Language Processing To Analyze Electronic Health Records. Philip Poon PhD Data Scientist
Using Natural Language Processing To Analyze Electronic Health Records Philip Poon PhD Data Scientist Agenda Overview of UnityPoint Health and Electronic Health Record Natural Language Processing development
More informationNCCN TRENDS DEMOGRAPHICS. Results: November 2013 NON-SMALL CELL LUNG CANCER. Distribution of Respondent Types (n = 835) Page 1
NCCN TRENDS Results: November 2013 NCCN Trends is an analytics tool from the National Comprehensive Cancer Network (NCCN ) that surveys how clinicians across the U.S. and around the globe are delivering
More informationInfrastructure for Clinical Data Exchange
Infrastructure for Clinical Data Exchange Amy Abernethy, MD, PhD FEBRUARY 29 2016 Instrument Data Highly Structured Administrative Data Highly Structured Clinical Research Data Intentionally Structured
More informationBoehringer Ingelheim Pharmaceuticals, Inc. & Univision. Making Diabetic Hispanics Healthier
Boehringer Ingelheim Pharmaceuticals, Inc. & Univision Making Diabetic Hispanics Healthier Agenda BIPI and the Hispanic segment Organizing and Executing to Win The Proof is in the Results Making Hispanics
More informationKnowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains
Knowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains Dr. Sascha Losko, Dr. Karsten Wenger, Dr. Wenzel Kalus, Dr. Andrea Ramge, Dr. Jens Wiehler,
More informationClinical NLP, PubGene Clinical trials in Coremine Oncology Text processing and information extraction for surgery planning form
Clinical NLP, PubGene Clinical trials in Coremine Oncology Text processing and information extraction for surgery planning form November 2017 Dag Are Steenhoff Hov, PubGene AS 1 PubGene, founded 2001 ArrayIt
More informationVeriStrat Poor Patients Show Encouraging Overall Survival and Progression Free Survival Signal; Confirmatory Phase 2 Study Planned by Year-End
AVEO and Biodesix Announce Exploratory Analysis of VeriStrat-Selected Patients with Non-Small Cell Lung Cancer in Phase 2 Study of Ficlatuzumab Presented at ESMO 2014 Congress VeriStrat Poor Patients Show
More informationMolecular Testing in Lung Cancer
Molecular Testing in Lung Cancer Pimpin Incharoen, M.D. Assistant Professor, Thoracic Pathology Department of Pathology, Ramathibodi Hospital Genetic alterations in lung cancer Source: Khono et al, Trans
More informationInnovative Risk and Quality Solutions for Value-Based Care. Company Overview
Innovative Risk and Quality Solutions for Value-Based Care Company Overview Meet Talix Talix provides risk and quality solutions to help providers, payers and accountable care organizations address the
More informationLooking for Subjectivity in Medical Discharge Summaries The Obesity NLP i2b2 Challenge (2008)
Looking for Subjectivity in Medical Discharge Summaries The Obesity NLP i2b2 Challenge (2008) Michael Roylance and Nicholas Waltner Tuesday 3 rd June, 2014 Michael Roylance and Nicholas Waltner Looking
More informationREFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) Executive Summary Tarceva (erlotinib): Key Metrics in NSCLC Markets 2012 Tarceva Sales US 5EU Japan China India
More informationWhole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute
Whole Genome and Transcriptome Analysis of Anaplastic Meningioma Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Outline Anaplastic meningioma compared to other cancers Whole genomes
More informationNAVIFY Tumor Board NAVIFY
NAVIFY Tumor Board Make the most informed personalized treatment decisions possible by leveraging innovative technologies and the latest scientific and clinical data WHAT S INSIDE Key Takeaways NAVIFY
More informationAVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits
AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect
More informationREFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) Executive Summary Xalkori (crizotinib): Key Metrics in NSCLC Markets 2012 Xalkori Sales US 5EU Japan China India
More informationREFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) AVASTIN (NON-SMALL CELL LUNG CANCER) - Executive Summary Avastin (bevacizumab): Key Metrics in NSCLC Markets 2012
More informationTHE ANALYTICS EDGE. Intelligence, Happiness, and Health x The Analytics Edge
THE ANALYTICS EDGE Intelligence, Happiness, and Health 15.071x The Analytics Edge Data is Powerful and Everywhere 2.7 Zettabytes of electronic data exist in the world today 2,700,000,000,000,000,000,000
More informationData Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis
February, 13th 2018 Data Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging and Pathology Expertise and Technologies:
More informationREFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) GILOTRIF (NON-SMALL CELL LUNG CANCER) - Executive Summary Gilotrif: Key Metrics in NSCLC Markets 2022 Gilotrif
More informationText Mining of Patient Demographics and Diagnoses from Psychiatric Assessments
University of Wisconsin Milwaukee UWM Digital Commons Theses and Dissertations December 2014 Text Mining of Patient Demographics and Diagnoses from Psychiatric Assessments Eric James Klosterman University
More informationREFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) Executive Summary Abraxane (nab-paclitaxel): Key Metrics in NSCLC Markets 2012 Abraxane Sales US 5EU $98.34m
More informationNCCN Non-Small Cell Lung Cancer V Meeting June 15, 2018
Guideline Page and Request Illumina Inc. requesting to replace Testing should be conducted as part of broad molecular profiling with Consider NGS-based assays that include EGFR, ALK, ROS1, and BRAF as
More informationStrandAdvantage Tissue-Specific Cancer Genomic Tests. Empowering Crucial First-Line Therapy Decisions for Your Patient
StrandAdvantage Tissue-Specific Cancer Genomic Tests Empowering Crucial First-Line Therapy Decisions for Your Patient Harness the power of precision medicine with StrandAdvantage Precision medicine in
More informationCorporate Medical Policy
Corporate Medical Policy Molecular Analysis for Targeted Therapy for Non-Small Cell Lung File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_analysis_for_targeted_therapy_for_non_small_cell_lung_cancer
More informationFrom Population Health to Precision Health. William J, Kassler, MD, MPH Deputy Chief Health Officer March 28, 2017
From Population Health to Precision Health William J, Kassler, MD, MPH Deputy Chief Health Officer March 28, 2017 2 The current health system faces serious challenges. 3 A New Era of Personalized Healthcare
More informationHow to Advance Beyond Regular Data with Text Analytics
Session #34 How to Advance Beyond Regular Data with Text Analytics Mike Dow Director, Product Development, Health Catalyst Carolyn Wong Simpkins, MD, PhD Chief Medical Informatics Officer, Health Catalyst
More informationALCHEMIST. Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trials
ALCHEMIST Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trials What is ALCHEMIST? ALCHEMIST is 3 integrated trials testing targeted therapy in early stage lung cancer: l A151216:
More informationWhat Smokers Who Switched to Vapor Products Tell Us About Themselves. Presented by Julie Woessner, J.D. CASAA National Policy Director
What Smokers Who Switched to Vapor Products Tell Us About Themselves Presented by Julie Woessner, J.D. CASAA National Policy Director The CASAA Consumer Testimonials Database Collection began in 2013 through
More informationStrategy Strategic delivery: Setting standards Increasing and informing choice. Details: Output: Demonstrating efficiency economy and value
Strategy 2017-20 Strategic delivery: Setting standards Increasing and informing choice Demonstrating efficiency economy and value Details: Meeting Authority Agenda item 7 Paper number HFEA (11/05/2016)
More informationThe 100,000 Genomes Project
The 100,000 Genomes Project Dr Matina Prapa, Scientific co ordinator Genomics England Clinical Interpretation Partnership William Harvey Research Institute Queen Mary University of London Genomics England
More informationCOMMITMENT &SOLUTIONS UNPARALLELED. Assessing Human Visual Inspection for Acceptance Testing: An Attribute Agreement Analysis Case Study
DATAWorks 2018 - March 21, 2018 Assessing Human Visual Inspection for Acceptance Testing: An Attribute Agreement Analysis Case Study Christopher Drake Lead Statistician, Small Caliber Munitions QE&SA Statistical
More informationCardiac CT Course Part A First step towards level 2 SCCT registration
29 September 2 October 2016 Philips Customer Education Center Business Central Towers, Dubai Internet City, Sheikh Zayed Road, Dubai, UAE The use of Multi-Detector CT (MDCT) in the diagnosis of various
More informationIMMUNOTHERAPY FOR LUNG CANCER
IMMUNOTHERAPY FOR LUNG CANCER Patient and Caregiver Guide IMMUNOTHERAPY FOR LUNG CANCER Patient and Caregiver Guide TABLE OF CONTENTS Lung Cancer Basics... 2 Immunotherapy... 3 FDA Approved Immunotherapies...
More informationNWCDC 2018 Pharmacy Analytics in Workers Comp
NWCDC 2018 Pharmacy Analytics in Workers Comp Cliff Belliveau VP Business Intelligence What is Visual Analytics? Transforming data into insights that tell a story 2 A little history Jacquard loom Punch
More informationEstablishing a Framework to Evaluate Real-World Endpoints
Establishing a Framework to Evaluate Real-World Endpoints Introduction July 10, 2018 Washington, DC Advances in data analytics and data capture through electronic health records (EHRs) and medical/pharmacy
More informationimmunotherapy a guide for the patient
immunotherapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2 immunotherapy... 5 Checkpoint Inhibitors... 6-9 Monoclonal Antibodies... 9 Vaccines... 10 Adoptive T-Cell
More informationLung Cancer Concept Annotation from Spanish Clinical Narratives
Lung Cancer Concept Annotation from Spanish Clinical Narratives Marjan Najafabadipour 1, [0000-0002-1428-9330], Juan Manuel Tuñas 1[0000-0001-8241-5602], Alejandro Rodríguez-González 1,2,* [0000-0001-8801-4762]
More informationOncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies
OncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies 2017 Contents Datasets... 2 Protein-protein interaction dataset... 2 Set of known PPIs... 3 Domain-domain interactions...
More informationWhere Are We Going: The Future of Cancer. Brenda Nevidjon, MSN, RN, FAAN Chief Executive Officer, ONS
Where Are We Going: The Future of Cancer Brenda Nevidjon, MSN, RN, FAAN Chief Executive Officer, ONS Imagine The future depends on what you do today. Mahatma Gandhi Cancer Today Globally, more deaths from
More informationONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20
More informationIBM Research Report. Automated Problem List Generation from Electronic Medical Records in IBM Watson
RC25496 (WAT1409-068) September 24, 2014 Computer Science IBM Research Report Automated Problem List Generation from Electronic Medical Records in IBM Watson Murthy Devarakonda, Ching-Huei Tsou IBM Research
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer Lisa Hess, Amy De Lozier,
More informationThree Rules for Measuring Physician Market Share
Crimson Market Advantage RESEARCH BRIEFING Three Rules for Measuring Physician Market Share Research and insights Performance Technologies Consulting and management Talent Development new definition Hospitals
More informationMulti-modal Patient Cohort Identification from EEG Report and Signal Data
Multi-modal Patient Cohort Identification from EEG Report and Signal Data Travis R. Goodwin and Sanda M. Harabagiu The University of Texas at Dallas Human Language Technology Research Institute http://www.hlt.utdallas.edu
More informationSound Off DR. GOOGLE S ROLE IN PRE-DIAGNOSIS THROUGH TREATMENT. Ipsos SMX. June 2014
Sound Off DR. GOOGLE S ROLE IN PRE-DIAGNOSIS THROUGH TREATMENT June 2014 Ipsos SMX : Sound bits (of advice) and bites (of research) from Ipsos SMX Ipsos social media research division, dedicated to providing
More informationDaniel Lieber, Ph.D. Senior Scientist, Computational Biology Foundation Medicine, Cambridge, MA. AACR 2017: Clinical Biomarkers April 3, 2017
Validation & clinical feasibility of a comprehensive genomic profiling assay to identify likely immunotherapy responders through tumor mutational burden (TMB) Daniel Lieber, Ph.D. Senior Scientist, Computational
More informationTIES Cancer Research Network Y2 Face to Face Meeting U24 CA October 29 th, 2014 University of Pennsylvania
TIES Cancer Research Network Y2 Face to Face Meeting U24 CA 180921 Session IV The Future of TIES October 29 th, 2014 University of Pennsylvania Afternoon Other Uses of TIES/Future of TIES 12:45-1:15 TIES
More informationMedia Release. Basel, 07 December 2017
Media Release Basel, 07 December 2017 Phase III IMpower150 study showed Tecentriq (atezolizumab) and Avastin (bevacizumab) plus chemotherapy reduced the risk of disease worsening or death by 38 percent
More informationSchema-Driven Relationship Extraction from Unstructured Text
Wright State University CORE Scholar Kno.e.sis Publications The Ohio Center of Excellence in Knowledge- Enabled Computing (Kno.e.sis) 2007 Schema-Driven Relationship Extraction from Unstructured Text Cartic
More informationIdentifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They?
Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Dubovenko Alexey Discovery Product Manager Sonia Novikova Solution Scientist September 2018 2 Non-Small Cell Lung Cancer
More informationThe Curing AI for Precision Medicine. Hoifung Poon
The Curing AI for Precision Medicine Hoifung Poon 1 Medicine Today Is Imprecise Top 20 drugs 80% non-responders Wasted 1/3 health spending $750 billion / year 2 Disruption 1: Big Data 2009 2013: 40% 93%
More information33 rd Annual J.P. Morgan Healthcare Conference. January 2015
33 rd Annual J.P. Morgan Healthcare Conference January 2015 Forward-looking Statements This presentation contains forward-looking statements, which express the current beliefs and expectations of management.
More informationEngaging People Strategy
Engaging People Strategy 2014-2020 Author: Rosemary Hampson, Public Partnership Co-ordinator Executive Lead Officer: Richard Norris, Director, Scottish Health Council Last updated: September 2014 Status:
More informationCardiac CT Course Part A First step towards level 2 SCCT registration
20-23 May 2016 Philips Customer Education Center Business Central Towers, Dubai Internet City, Sheikh Zayed Road, Dubai, UAE The use of Multi-Detector CT (MDCT) in the diagnosis of various cardiac diseases
More informationSystems Thinking in Personalized Medicine
Systems Thinking in Personalized Medicine Devon C. Campbell Head, Engineering and Systems Novartis Molecular Diagnostics MIT SDM Systems Thinking Conference October 25, 2011 Agenda Personalized medicine
More informationLogistics of Alchemist Screening Trial A Shauna Hillman, Statistician Chelsea Schultz, Data Manager Alliance SDC
Logistics of Alchemist Screening Trial A151216 Shauna Hillman, Statistician Chelsea Schultz, Data Manager Alliance SDC Alliance Fall Meeting Nov, 2014 Presentation Objectives To Provide Background and
More informationAn Introduction to Acute Kidney Injury (AKI) An Education Package for Healthcare Professionals in Medical Directorates
An Introduction to Acute Kidney Injury (AKI) An Education Package for Healthcare Professionals in Medical Directorates STH Acute Kidney Injury (AKI) Project 1 What is Acute Kidney Injury (AKI)? AKI is
More informationThe Patient Journey Evolution
The Patient Journey Evolution A Case Study Alex Zhu & Bill Salokar SKIM 1 Digital is transforming business and Healthcare is no exception 70% US consumers use a digital channel to manage health & wellness
More informationBigomics : Challenges and promises in large scale sequencing projects
Bigomics : Challenges and promises in large scale sequencing projects Theodore M. Wong Ken Yocum MSST 2014 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life,
More informationBigMedilytics Big Data for Medical Analytics
01010010010100100100010101001 010100010100010 01010 10010010010001010 01010010010010010010010 0100100100010001001001001 BigMedilytics Big Data for Medical Analytics 001010010100101 1010010010001001001
More informationPredictive Analytics and machine learning in clinical decision systems: simplified medical management decision making for health practitioners
Predictive Analytics and machine learning in clinical decision systems: simplified medical management decision making for health practitioners Mohamed Yassine, MD Vice President, Head of US Medical Affairs
More informationMemory-Augmented Active Deep Learning for Identifying Relations Between Distant Medical Concepts in Electroencephalography Reports
Memory-Augmented Active Deep Learning for Identifying Relations Between Distant Medical Concepts in Electroencephalography Reports Ramon Maldonado, BS, Travis Goodwin, PhD Sanda M. Harabagiu, PhD The University
More informationNCCN TRENDS DEMOGRAPHICS. Results: January 2013 NON-SMALL CELL LUNG CANCER. Distribution of Respondent Types (n = 1,055) Page 1
NCCN TRENDS Results: January 2013 NCCN Trends is an analytics tool from the National Comprehensive Cancer Network (NCCN ) that surveys how clinicians across the U.S. and around the globe are delivering
More informationBut How Do You Know It s Working?
But How Do You Know It s Working? Outcome Measurement and Evaluation MARY HANIFIN SENIOR MANAGING DIRECTOR, DEVELOPMENT MASSACHUSETTS GENERAL HOSPITAL LABRINI NELLIGAN EXECUTIVE DIRECTOR LUNDER- DINEEN
More information212/ ; ;
Contact: Diana Franco, Ballantine Tammy Richards-LeSure, Richards Public Relations 212/572-2533; dfranco@randomhouse.com 817-453-6166; richardspr@charter.net The Love Response Your Prescription to Turn
More informationCognitive Health in the Workplace
Mild Cognitive Impairment: Uncovering the Impact on an Ageing Workforce Cognitive Health in the Workplace Dr Jenny Barnett Director, Healthcare Innovation CANTAB Corporate Health Validated by 30 years
More informationIn all of these roles, I've used healthcare data to drive strategy for the life sciences industry.
Intro: When you take a magnifying glass and look at a picture, you see that it's made up of thousands of dots and when you pull back, those dots become the details that create the picture. There's real
More informationA Language Modeling Approach for Temporal Information Needs
A Language Modeling Approach for Temporal Information Needs Klaus Berberich, Srikanta Bedathur Omar Alonso, Gerhard Weikum 2010, March 29th ECIR 2010 Milton Keynes Motivation Information needs having a
More informationMacmillan Cancer Support s offer to support the development of - Cancer information and support and benefits advice services for people affected by
Macmillan Cancer Support s offer to support the development of - Cancer information and support and benefits advice services for people affected by cancer www.macmillan.org.uk/servicesimpact Page 1 of
More informationApplication of AI in Healthcare. Alistair Erskine MD MBA Chief Informatics Officer
Application of AI in Healthcare Alistair Erskine MD MBA Chief Informatics Officer 1 Overview Why AI in Healthcare topic matters Is AI just another shiny objects? Geisinger AI collaborations Categories
More informationUNDERSTANDING SQUAMOUS CELL LUNG CANCER
UNDERSTANDING SQUAMOUS CELL LUNG CANCER A guide for patients and caregivers FREE TO BREATHE SUPPORT LINE (844) 835-4325 A FREE resource for lung cancer patients & caregivers About this brochure This brochure
More informationCLINICIAN-LED E-HEALTH RECORDS. (AKA GETTING THE LITTLE DATA RIGHT) Dr Heather Leslie Ocean Informatics/openEHR Foundation
CLINICIAN-LED E-HEALTH RECORDS (AKA GETTING THE LITTLE DATA RIGHT) Dr Heather Leslie Ocean Informatics/openEHR Foundation An ongoing issue In attempting to arrive at the truth, I have applied everywhere
More informationMaster of Business Administration: Fall 2017/Spring 2018/Fall Semesters (45 Credits)
Master of Business Administration: Fall 2017/Spring 2018/Fall 2018-3 Semesters (45 Credits) 4 Required non-credit courses: MGMT 6010 Heroes, Leaders & Innovators (Fall) TBA MGMT 7230 Professional Development
More informationChapter 12 Conclusions and Outlook
Chapter 12 Conclusions and Outlook In this book research in clinical text mining from the early days in 1970 up to now (2017) has been compiled. This book provided information on paper based patient record
More informationDELIVERING OUR STRATEGY: FOR YOU, WITH YOU
#wearenhft Northamptonshire Healthcare NHS Foundation Trust DELIVERING OUR STRATEGY: FOR YOU, WITH YOU OUR STRATEGIC PLAN: 2018-2023 01604 682682 01604 682682 nhft.nhs.uk FOR YOU, WITH YOU ABOUT NHFT We
More informationA Study of Abbreviations in Clinical Notes Hua Xu MS, MA 1, Peter D. Stetson, MD, MA 1, 2, Carol Friedman Ph.D. 1
A Study of Abbreviations in Clinical Notes Hua Xu MS, MA 1, Peter D. Stetson, MD, MA 1, 2, Carol Friedman Ph.D. 1 1 Department of Biomedical Informatics, Columbia University, New York, NY, USA 2 Department
More informationAn Interactive Guide to ALK+ Lymphoma. Our understanding of lung cancer has changed From one disease to many subtypes LCD
An Interactive Guide to ALK+ Anaplastic Lymphoma Kinase Non-Small Cell Lung (NSCLC) Our understanding of lung cancer has changed From one disease to many subtypes Click to get started Learning about Lung
More informationShades of Certainty Working with Swedish Medical Records and the Stockholm EPR Corpus
Shades of Certainty Working with Swedish Medical Records and the Stockholm EPR Corpus Sumithra VELUPILLAI, Ph.D. Oslo, May 30 th 2012 Health Care Analytics and Modeling, Dept. of Computer and Systems Sciences
More informationNon-Small Cell Lung Cancer Webinar. Thursday, September 13, p.m. EDT
Non-Small Cell Lung Cancer Webinar Thursday, September 13, 2018 1 2 p.m. EDT 1 2 Webinar Faculty Julie R. Brahmer, MD Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Patrick Forde, MD Johns
More informationPersonalized Treatment Approaches for Lung Cancer
Personalized Treatment Approaches for Lung Cancer California Thoracic Society 2018 Annual Carmel Conference January 27, 2018 Matthew Gubens, MD, MS Associate Professor of Medicine Chair, Thoracic Oncology
More informationPositioned for Growth
Positioned for Growth Annual Shareholders Meeting July 21, 2016 Paris Panayiotopoulos President and Chief Executive Officer David Sachs Non small cell lung cancer ARIAD clinical trial patient This presentation
More informationRegulatory Landscape for Precision Medicine
Regulatory Landscape for Precision Medicine Adam C. Berger, Ph.D. Office of In Vitro Diagnostics and Radiological Health, FDA FOCR-Alexandria A Blueprint for Breakthrough Meeting September 13, 2017 1 What
More informationNCCN Non Small Cell Lung Cancer V Meeting July 8, 2016
NSCL 3 Submission from Myriad requesting the following statement to be listed as an additional high risk factor in footnote p : For lung ADC, a highrisk 46 gene molecular prognostic score determined by
More informationMAKING DECISIONS TOGETHER. Being an Active Partner in Your Treatment and Recovery
MAKING DECISIONS TOGETHER Being an Active Partner in Your Treatment and Recovery The Journey of Mental Health Recovery U.S. Adults Living With: Schizophrenia 10 out of 1000 Schizoaffective 2 to 5 out of
More informationMedical Treatment of Advanced Lung Cancer
Medical Treatment of Advanced Lung Cancer Oncology for Scientists April 26, 2018 Edwin Yau, MD., Ph.D. Assistant Professor of Oncology Department of Medicine Department of Cancer Genetics and Genomics
More informationB I ABOUT BI DISEASE AREA & MECHANISM OF ACTION. For journalists outside UK/US/Canada only B A C K G R O U N D E R
For journalists outside UK/US/Canada only B I 1 4 8 2 6 9 4 1. About BI 1482694 2. Disease area & mechanism of action 3. Development status 4. Data overview 1. ABOUT BI 1482694 BI 1482694* (HM61713**)
More informationOpen Research Online The Open University s repository of research publications and other research outputs
Open Research Online The Open University s repository of research publications and other research outputs Toward Emotionally Accessible Massive Open Online Courses (MOOCs) Conference or Workshop Item How
More informationA Guide to Reading a Clinical or Research Publication
A Guide to Reading a Clinical or Research Publication For people living with a rare disease, being able to read and understand the information found in a clinical or research publication can be especially
More informationFor a legacy that lives large: Think Big. Philips CT Big Bore. Computed tomography
Computed tomography For a legacy that lives large: Think Big Philips CT Big Bore The big question The world of cancer care is rapidly changing. The number of new cancer cases is expected to rise by about
More informationTPMI Presents: Translational Genomics Research Update, Opportunities and Challenges
TPMI Presents: Translational Genomics Research Update, Opportunities and Challenges April 12, 2016 Darren D. O Rielly, Ph.D., FCCMG Director, Molecular Genetics Laboratory, Eastern Health Director, Translational
More informationCorporate Medical Policy
Corporate Medical Policy Proteomic Testing for Targeted Therapy in Non-Small Cell Lung File Name: Origination: Last CAP Review: Next CAP Review: Last Review: proteomic_testing_for_targeted_therapy_in_non_small_cell_lung_cancer
More informationExperiments with CST-based Multi-document Summarization
Experiments with CST-based Multi-document Summarization Maria Lucia R. Castro Jorge mluciacj@icmc.usp.br Thiago A.S. Pardo taspardo@icmc.usp.br NLP Group - University of São Paulo Multi-document Summarization
More informationCardiac CT Course Part A First step towards level 2 SCCT registration
29 September 2 October 2017 Philips Customer Education Center Business Central Towers, Dubai Internet City, Sheikh Zayed Road, Dubai, UAE The use of Multi-Detector CT (MDCT) in the diagnosis of various
More information